Ibuprofen may improve liver-related brain deficits

Treatment with the commonly used over-the-counter drug ibuprofen (Motrin, Advil), may reduce the impairments in thinking ability that often accompany severe liver disease, findings from an animal study suggest.

Ibuprofen is an anti-inflammatory agent that belongs to a group of drugs called non-steroidal anti-inflammatory drugs (NSAIDs). Previous research has suggested that inflammation plays a key role in the development of brain impairments caused by liver disease, referred to as “hepatic encephalopathy.”

In the new study, Dr. Vicente Felipo of the Centro de Investigacion Principe Felipe in Valencia, Spain, and colleagues showed that rats with hepatic encephalopathy have nerve inflammation in the brain and difficulty learning a simple maze task.

However, after the long-term use of ibuprofen, the ability of the rats to learn the maze was completely restored, the researchers report in the journal Hepatology.

These observations support “the idea that reducing inflammation would improve (thinking ability) in patients with hepatic encephalopathy,” Felipo and colleagues suggest.

SOURCE: Hepatology, August 2007.

Print Version
Tell-a-Friend

RELATED ARTICLES:

People With Intellectual Disabilities Face Health Care Hurdles   Occasional Memory Loss Tied to Lower Brain Volume   During exercise, the human brain shifts into high gear on ‘alternative energy’   New marker for raised intracranial pressure   Treatment for Parkinson’s examined   Hypnosis shown to reduce symptoms of dementia   Obsessive compulsive disorder linked to brain activity   Man says prescription drug caused gambling problem   Alcoholism-associated molecular adaptations in brain neurocognitive circuits   ‘Mind’s eye’ influences visual perception   New oral drug curbs MS disease activity   Known Genetic Risk for Alzheimer’s in Whites Also Places Blacks at Risk